nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—CXCR4—acquired immunodeficiency syndrome	0.81	1	CbGaD
Framycetin—CXCR4—Binding and entry of HIV virion—CCR5—acquired immunodeficiency syndrome	0.0106	0.117	CbGpPWpGaD
Framycetin—CXCR4—endothelium—acquired immunodeficiency syndrome	0.0087	0.181	CbGeAlD
Framycetin—Malabsorption—Efavirenz—acquired immunodeficiency syndrome	0.00773	0.15	CcSEcCtD
Framycetin—CXCR4—blood plasma—acquired immunodeficiency syndrome	0.00772	0.161	CbGeAlD
Framycetin—CXCR4—Binding and entry of HIV virion—CD4—acquired immunodeficiency syndrome	0.00666	0.0734	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL3L1—acquired immunodeficiency syndrome	0.00589	0.0649	CbGpPWpGaD
Framycetin—CXCR4—retina—acquired immunodeficiency syndrome	0.00423	0.0882	CbGeAlD
Framycetin—Sensitisation—Abacavir—acquired immunodeficiency syndrome	0.00405	0.0785	CcSEcCtD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—CCR5—acquired immunodeficiency syndrome	0.0039	0.0429	CbGpPWpGaD
Framycetin—Sensitisation—Zidovudine—acquired immunodeficiency syndrome	0.00357	0.0692	CcSEcCtD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL4—acquired immunodeficiency syndrome	0.00323	0.0356	CbGpPWpGaD
Framycetin—CXCR4—lymphoid tissue—acquired immunodeficiency syndrome	0.00301	0.0627	CbGeAlD
Framycetin—CXCR4—digestive system—acquired immunodeficiency syndrome	0.00297	0.0619	CbGeAlD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00293	0.0323	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.00286	0.0315	CbGpPWpGaD
Framycetin—CXCR4—blood—acquired immunodeficiency syndrome	0.00283	0.059	CbGeAlD
Framycetin—CXCR4—bone marrow—acquired immunodeficiency syndrome	0.00274	0.0571	CbGeAlD
Framycetin—CXCR4—spinal cord—acquired immunodeficiency syndrome	0.00273	0.0568	CbGeAlD
Framycetin—CXCR4—vagina—acquired immunodeficiency syndrome	0.00262	0.0547	CbGeAlD
Framycetin—Sensitisation—Lamivudine—acquired immunodeficiency syndrome	0.00255	0.0494	CcSEcCtD
Framycetin—CXCR4—lung—acquired immunodeficiency syndrome	0.00248	0.0517	CbGeAlD
Framycetin—CXCR4—Early Phase of HIV Life Cycle—CD4—acquired immunodeficiency syndrome	0.00245	0.027	CbGpPWpGaD
Framycetin—CXCR4—nervous system—acquired immunodeficiency syndrome	0.0023	0.0479	CbGeAlD
Framycetin—CXCR4—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.00223	0.0246	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00222	0.0244	CbGpPWpGaD
Framycetin—CXCR4—central nervous system—acquired immunodeficiency syndrome	0.00221	0.0461	CbGeAlD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL3—acquired immunodeficiency syndrome	0.00221	0.0243	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCR2—acquired immunodeficiency syndrome	0.00199	0.022	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CXCL12—acquired immunodeficiency syndrome	0.00188	0.0207	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—CSF2—acquired immunodeficiency syndrome	0.00184	0.0203	CbGpPWpGaD
Framycetin—CXCR4—brain—acquired immunodeficiency syndrome	0.00176	0.0366	CbGeAlD
Framycetin—CXCR4—HIV Life Cycle—CCNT1—acquired immunodeficiency syndrome	0.00176	0.0193	CbGpPWpGaD
Framycetin—CXCR4—lymph node—acquired immunodeficiency syndrome	0.0017	0.0354	CbGeAlD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.00164	0.0181	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0016	0.0176	CbGpPWpGaD
Framycetin—Glaucoma—Efavirenz—acquired immunodeficiency syndrome	0.00149	0.0288	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00149	0.0164	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCL5—acquired immunodeficiency syndrome	0.00143	0.0157	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—APOBEC3G—acquired immunodeficiency syndrome	0.00143	0.0157	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00136	0.0149	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00134	0.0148	CbGpPWpGaD
Framycetin—CXCR4—Chemokine receptors bind chemokines—CCR5—acquired immunodeficiency syndrome	0.00129	0.0142	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00121	0.0134	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CCNT1—acquired immunodeficiency syndrome	0.00121	0.0134	CbGpPWpGaD
Framycetin—Viral infection—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.023	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00113	0.0125	CbGpPWpGaD
Framycetin—CXCR4—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00103	0.0113	CbGpPWpGaD
Framycetin—Viral infection—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0195	CcSEcCtD
Framycetin—Swelling—Indinavir—acquired immunodeficiency syndrome	0.000977	0.0189	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000901	0.00993	CbGpPWpGaD
Framycetin—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.000883	0.0171	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00083	0.00914	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000815	0.00898	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00075	0.00827	CbGpPWpGaD
Framycetin—CXCR4—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000706	0.00777	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000686	0.00756	CbGpPWpGaD
Framycetin—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.000665	0.0129	CcSEcCtD
Framycetin—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.000644	0.0125	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000633	0.00697	CbGpPWpGaD
Framycetin—CXCR4—HIV Life Cycle—CCR5—acquired immunodeficiency syndrome	0.000632	0.00696	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00062	0.00684	CbGpPWpGaD
Framycetin—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.000604	0.0117	CcSEcCtD
Framycetin—Infection—Didanosine—acquired immunodeficiency syndrome	0.0006	0.0116	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000595	0.00656	CbGpPWpGaD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000588	0.00647	CbGpPWpGaD
Framycetin—CXCR4—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000583	0.00643	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000581	0.0064	CbGpPWpGaD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—acquired immunodeficiency syndrome	0.000571	0.00629	CbGpPWpGaD
Framycetin—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.0108	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000557	0.00613	CbGpPWpGaD
Framycetin—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.000543	0.0105	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000537	0.00591	CbGpPWpGaD
Framycetin—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000516	0.01	CcSEcCtD
Framycetin—Infection—Abacavir—acquired immunodeficiency syndrome	0.000513	0.00993	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000503	0.00555	CbGpPWpGaD
Framycetin—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.0095	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000484	0.00533	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000473	0.00521	CbGpPWpGaD
Framycetin—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.00909	CcSEcCtD
Framycetin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000468	0.00907	CcSEcCtD
Framycetin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000456	0.00882	CcSEcCtD
Framycetin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000453	0.00877	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000453	0.00499	CbGpPWpGaD
Framycetin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000445	0.00861	CcSEcCtD
Framycetin—CXCR4—HIV Infection—CCR5—acquired immunodeficiency syndrome	0.000436	0.00481	CbGpPWpGaD
Framycetin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000427	0.00827	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000424	0.00467	CbGpPWpGaD
Framycetin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000424	0.0082	CcSEcCtD
Framycetin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000421	0.00815	CcSEcCtD
Framycetin—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000418	0.00809	CcSEcCtD
Framycetin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000413	0.008	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000408	0.00449	CbGpPWpGaD
Framycetin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.0004	0.00774	CcSEcCtD
Framycetin—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.00772	CcSEcCtD
Framycetin—CXCR4—HIV Life Cycle—CD4—acquired immunodeficiency syndrome	0.000397	0.00437	CbGpPWpGaD
Framycetin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000393	0.00762	CcSEcCtD
Framycetin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000387	0.0075	CcSEcCtD
Framycetin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000386	0.00748	CcSEcCtD
Framycetin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000384	0.00744	CcSEcCtD
Framycetin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000384	0.00743	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000383	0.00422	CbGpPWpGaD
Framycetin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00038	0.00737	CcSEcCtD
Framycetin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00038	0.00737	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000379	0.00417	CbGpPWpGaD
Framycetin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000372	0.0072	CcSEcCtD
Framycetin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000371	0.00719	CcSEcCtD
Framycetin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000371	0.00718	CcSEcCtD
Framycetin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000365	0.00707	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00036	0.00397	CbGpPWpGaD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00036	0.00397	CbGpPWpGaD
Framycetin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00036	0.00696	CcSEcCtD
Framycetin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000359	0.00694	CcSEcCtD
Framycetin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000359	0.00694	CcSEcCtD
Framycetin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000353	0.00684	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000352	0.00388	CbGpPWpGaD
Framycetin—CXCR4—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000349	0.00385	CbGpPWpGaD
Framycetin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000345	0.00668	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000343	0.00378	CbGpPWpGaD
Framycetin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000339	0.00656	CcSEcCtD
Framycetin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000334	0.00647	CcSEcCtD
Framycetin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000333	0.00645	CcSEcCtD
Framycetin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000328	0.00636	CcSEcCtD
Framycetin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.0063	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000324	0.00357	CbGpPWpGaD
Framycetin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.00626	CcSEcCtD
Framycetin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000322	0.00624	CcSEcCtD
Framycetin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00624	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000318	0.00351	CbGpPWpGaD
Framycetin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000312	0.00605	CcSEcCtD
Framycetin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000312	0.00604	CcSEcCtD
Framycetin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00603	CcSEcCtD
Framycetin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000311	0.00603	CcSEcCtD
Framycetin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000307	0.00594	CcSEcCtD
Framycetin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.0003	0.0058	CcSEcCtD
Framycetin—CXCR4—Disease—CCNT1—acquired immunodeficiency syndrome	0.000297	0.00327	CbGpPWpGaD
Framycetin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00571	CcSEcCtD
Framycetin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00029	0.00561	CcSEcCtD
Framycetin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00029	0.00561	CcSEcCtD
Framycetin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00548	CcSEcCtD
Framycetin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00546	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000274	0.00302	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—CD4—acquired immunodeficiency syndrome	0.000274	0.00302	CbGpPWpGaD
Framycetin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.0053	CcSEcCtD
Framycetin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.00525	CcSEcCtD
Framycetin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.00524	CcSEcCtD
Framycetin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00522	CcSEcCtD
Framycetin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00507	CcSEcCtD
Framycetin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00505	CcSEcCtD
Framycetin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.00493	CcSEcCtD
Framycetin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000252	0.00487	CcSEcCtD
Framycetin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00486	CcSEcCtD
Framycetin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.00485	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000247	0.00272	CbGpPWpGaD
Framycetin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00471	CcSEcCtD
Framycetin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00469	CcSEcCtD
Framycetin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.00467	CcSEcCtD
Framycetin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00464	CcSEcCtD
Framycetin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.0046	CcSEcCtD
Framycetin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00452	CcSEcCtD
Framycetin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00445	CcSEcCtD
Framycetin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.0044	CcSEcCtD
Framycetin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.00436	CcSEcCtD
Framycetin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00431	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000218	0.0024	CbGpPWpGaD
Framycetin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.0042	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000217	0.00239	CbGpPWpGaD
Framycetin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.00407	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000208	0.00229	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000208	0.00229	CbGpPWpGaD
Framycetin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.004	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000204	0.00224	CbGpPWpGaD
Framycetin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00392	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000197	0.00217	CbGpPWpGaD
Framycetin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.00374	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000188	0.00207	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000185	0.00204	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000155	0.00171	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000153	0.00168	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000141	0.00155	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00014	0.00154	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000139	0.00153	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000128	0.00142	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000127	0.0014	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000116	0.00128	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000109	0.0012	CbGpPWpGaD
Framycetin—CXCR4—Disease—CCR5—acquired immunodeficiency syndrome	0.000107	0.00118	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.31e-05	0.000916	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.19e-05	0.000902	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.07e-05	0.000889	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.49e-05	0.000825	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.32e-05	0.000807	CbGpPWpGaD
Framycetin—CXCR4—Disease—CD4—acquired immunodeficiency syndrome	6.72e-05	0.00074	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.33e-05	0.000477	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.31e-05	0.000474	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—acquired immunodeficiency syndrome	3.63e-05	0.0004	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.54e-05	0.00028	CbGpPWpGaD
